|Guidelines for good clinical practice (GCP) for trials on pharmaceutical products (WHO Technical Report Series, No. 850, 1995, Annex 3) (WHO, 1995, 36 p.)|
|4. RESPONSIBILITIES OF THE INVESTIGATOR|
In clinical trials in which the investigator is the sponsor, he or she is responsible for the corresponding functions (see Section 5).